Human Metabolome Technologies, Inc. Stock price
Equities
6090
JP3794530000
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
650 JPY | -0.46% | +2.36% | +1.56% |
Sales 2022 | 1.22B 8.08M | Sales 2023 | 1.3B 8.58M | Capitalization | 4.42B 29.22M |
---|---|---|---|---|---|
Net income 2022 | 267M 1.76M | Net income 2023 | 285M 1.88M | EV / Sales 2022 | 2.48 x |
Net cash position 2022 | 1.27B 8.4M | Net cash position 2023 | 1.43B 9.45M | EV / Sales 2023 | 2.31 x |
P/E ratio 2022 |
16.1
x | P/E ratio 2023 |
15.5
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
1.34% | Free-Float | 80.56% |
1 day | -0.46% | ||
1 week | +2.36% | ||
Current month | +3.34% | ||
1 month | +3.67% | ||
3 months | +5.18% | ||
6 months | -11.56% | ||
Current year | +1.56% |
Managers | Title | Age | Since |
---|---|---|---|
President | 55 | 18-02-28 | |
Tomomi Ishihara
ADM | Chief Administrative Officer | - | - |
Takaomi Fukuhara
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yasuhiro Ohata
BRD | Director/Board Member | 58 | 20-06-30 |
Corporate Officer/Principal | 49 | 05-06-30 | |
Toshio Nagae
BRD | Director/Board Member | 80 | 17-06-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 650 | -0.46% | 4 000 |
24-03-27 | 653 | +1.56% | 6,100 |
24-03-26 | 643 | +0.16% | 8,700 |
24-03-25 | 642 | +0.78% | 8,500 |
24-03-22 | 637 | +0.31% | 3,700 |
Delayed Quote Japan Exchange, March 28, 2024 at 02:00 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+1.56% | 25.52M | |
+9.16% | 45.97B | |
+54.37% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |